1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Pazoo, Inc.

Pazoo, Inc.

PZOO
Pazoo, Inc.US flagOther OTC
0.00
USD
- -
- -
26,882.00Market Cap
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
TTM
Revenue per Share
1.13
48.95
15.42
21.43
1.02
0.01
- -
- -
Basic EPS, GAAP
-90.49
-665.02
-211.44
-963.73
-172.37
-3.28
- -
-0.1
Free Cash Flow per Basic Share
-69.36
-411.52
-108.9
-245.27
-85.45
-0.35
- -
-0.03
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-66.33
-707.65
-706.06
-1,428.47
-453.34
-7.72
- -
-0.69
Tangible Book Value per Share
-22.05
56.75
-49.18
-536.9
-155.05
-3.18
- -
-0.32
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
3
- -
34
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-7,405.5
-1,325.88
-1,014.17
-2,128.11
-15,284.83
-9,543.75
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-2
-1
-5
-4
-9
-4
-4
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-7,998.94
-1,325.93
-1,245.32
-4,402.66
-16,798.16
-28,823.44
- -
- -
Working Capital
- -
- -
- -
-3
-4
-8
-10
-10
LT Debt
- -
- -
- -
- -
- -
2
1
1
Total Equity
- -
- -
- -
-3
-2
-9
-11
-11
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
-15.32
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'17
Sep'17
Dec'17
ST Debt
3
3
2
LT Borrowings
1
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
34
124
613
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Jun'17
Sep'17
Dec'17
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
9
11
10
Payables & Accruals
3
3
3
ST Debt
3
3
2
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
324.8%
30.41%
Free Cash Flow
- -
38.68%
-2.49%
Net Income, GAAP
- -
122.93%
-59.7%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
-6.77%
-1.32%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
-164.16
-94.97
62.03
- -
-172.37
2016
-52.03
-10.84
-0.04
- -
-3.28
2017
-0.2
0.04
-0.04
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Steven Basloe
Full Time Employees
4
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
34 DeForest Avenue East Hanover NJ United States of America 07936
IPO Date
Jun 27, 2012
CIK
0001533427
Website
pazoo.com
Similar Companies
Mankind Pharma Limited (MANKIND.BO)
ANI Pharmaceuticals, Inc. (ANIP)
Go Life International Limited (GLI.JO)
Landec Corporation (LNDC)
Rubicon Organics Inc. (ROMJF)
Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS)
Business
Pazoo, Inc. operates within the health and wellness sphere, having undergone notable business evolution. Historically, the company provided laboratory testing services for cannabis products and engaged in the online retail of various nutritional and wellness items, alongside fitness apparel. It previously maintained a digital platform offering expert advice and e-commerce solutions for both human and pet well-being. As of late 2024, Pazoo, Inc. functions primarily as a shell company, actively seeking and pursuing new ventures after divesting its former operational assets. The company was established in 2010 and maintains its headquarters in East Hanover, New Jersey.

Company News

APIChat